Abbott Laboratories (ABT) 재무상태표
NYSE · Healthcare · Medical - Devices · 직원 115,000명 · CEO Robert Ford
- 주가
- $106.20 +1.56%
- 시가총액
- $1840억
- 기업가치
- $2110억
- 최근 실적
- Q3 '26 2026-09-30 제출
- 다음 실적
- 2027-01-28 EPS 추정 $1.64
Abbott Laboratories (ABT)의 Q2 '26말 현금 및 단기투자는 $56억, 리스 포함 차입금은 $326억입니다. 자산총계 $1090억, 부채총계 $575억, 주주지분 $511억.
재무상태표
| 재무상태표 | 추세 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $67.1억 | $69억 | $62.8억 | $69.9억 | $75.6억 | $76.2억 | $65.3억 | $69.5억 | $75.1억 | $85.2억 | $68억 | $51억 | |
| 단기투자 | $3.38억 | $3.83억 | $3.67억 | $2.32억 | $2.3억 | $3.51억 | $3.12억 | $3.31억 | $2.22억 | $4.17억 | $4.92억 | $4.99억 | |
| 매출채권 | $65억 | $65.7억 | $66.1억 | $68.5억 | $70.5억 | $69.3억 | $73.3억 | $79.7억 | $81.4억 | $79.3억 | $82.1억 | $86억 | |
| 재고자산 | $66.5억 | $65.7억 | $68.3억 | $68.1억 | $68.1억 | $61.9억 | $66.4억 | $69.5억 | $67.1억 | $64.9억 | $69.9억 | $73.2억 | |
| 기타 유동자산 | $24.7억 | $22.6억 | $22.9억 | $22.3억 | $21.5억 | $25.7억 | $23.4억 | $22.6억 | $22.6억 | $26.4억 | $30.1억 | $30억 | |
| 유동자산 | $227억 | $227억 | $224억 | $231억 | $238억 | $237억 | $232억 | $245억 | $248억 | $260억 | $255억 | $245억 | |
| 유형자산(순액) | $95.5억 | $113억 | $101억 | $102억 | $106억 | $117억 | $109억 | $114억 | $115억 | $129억 | $124억 | $128억 | |
| 장기투자 | $7.88억 | $7.99억 | $8.18억 | $8.77억 | $9.12억 | $8.86억 | $9.07억 | $9.58억 | $9.51억 | $9.18억 | $10.9억 | $11.1억 | |
| 영업권 | $233억 | $237억 | $234억 | $233억 | $237억 | $231억 | $234억 | $240억 | $240억 | $240억 | $352억 | $352억 | |
| 무형자산 | $92.8억 | $88.2억 | $83억 | $78.3억 | $73.5억 | $66.5억 | $62.6억 | $59.2억 | $56억 | $55.3억 | $179억 | $172억 | |
| 기타 비유동자산 | $65.3억 | $59.8억 | $74.9억 | $76.5억 | $80.1억 | $154억 | $168억 | $173억 | $173억 | $173억 | $184억 | $183억 | |
| 비유동자산 | $494억 | $505억 | $501억 | $499억 | $506억 | $578억 | $583억 | $595억 | $593억 | $607억 | $849억 | $847억 | |
| 자산총계 | $721억 | $732억 | $725억 | $730억 | $744억 | $814억 | $814억 | $840억 | $842억 | $867억 | $1100억 | $1090억 | |
| 부채 | |||||||||||||
| 매입채무 | $39.6억 | $43억 | $41.8억 | $41.3억 | $40.3억 | $42억 | $42.1억 | $43.1억 | $41.2억 | $42.4억 | $46.8억 | $47.9억 | |
| 미지급비용 | $14.8억 | $16억 | $10.9억 | $13.9억 | $16.2억 | $17억 | $11.7억 | $15.5억 | $17.4억 | $17.5억 | $75.9억 | $85.1억 | |
| 단기차입금 | $10.5억 | $13.3억 | $20.1억 | $16.2억 | $21.5억 | $17.5억 | $5.06억 | $5.07억 | $13.5억 | $33.1억 | $44.1억 | $30.1억 | |
| 미지급세금 | $3.18억 | $4.92억 | $5.62억 | $6.01억 | $7.13억 | $5.94억 | $4.85억 | $3.9억 | $4.69억 | $5.69억 | $5.98억 | $4.11억 | |
| 기타 유동부채 | $62.3억 | $61.3억 | $61.8억 | $60.3억 | $63.8억 | $59.1억 | $66.3억 | $66.9억 | $69.1억 | $55.4억 | $0 | $0 | |
| 유동부채 | $130억 | $138억 | $140억 | $138억 | $149억 | $142억 | $130억 | $134억 | $146억 | $165억 | $184억 | $178억 | |
| 장기차입금 | $145억 | $136억 | $126억 | $131억 | $128억 | $126억 | $127억 | $129억 | $116억 | $108억 | $296억 | $296억 | |
| 리스부채(비유동) | $0 | $9.49억 | $0 | $0 | $0 | $8.96억 | $0 | $0 | $0 | $9.31억 | $0 | $0 | |
| 이연법인세부채 | $0 | $12.2억 | $0 | $0 | $0 | $13.7억 | $0 | $0 | $0 | $19.6억 | $0 | $0 | |
| 기타 비유동부채 | $68.8억 | $47.8억 | $68.3억 | $65.6억 | $66억 | $44.6억 | $66.4억 | $68억 | $67.4억 | $37.3억 | $97.1억 | $100억 | |
| 비유동부채 | $214억 | $205억 | $194억 | $197억 | $194억 | $194억 | $194억 | $197억 | $183억 | $174억 | $394억 | $396억 | |
| 부채총계 | $344억 | $344억 | $334억 | $335억 | $343억 | $335억 | $324억 | $332억 | $329억 | $339억 | $577억 | $575억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $247억 | $249억 | $247억 | $249억 | $250억 | $252억 | $251억 | $253억 | $254억 | $255억 | $254억 | $255억 | |
| 이익잉여금 | $369억 | $376억 | $380억 | $384억 | $391억 | $473억 | $477억 | $485억 | $491억 | $498억 | $500억 | $498억 | |
| 기타포괄손익누계액 | -$84.8억 | -$78.4억 | -$81.7억 | -$81.4억 | -$78억 | -$79.1억 | -$74.2억 | -$65.8억 | -$66.8억 | -$60억 | -$63.1억 | -$62.1억 | |
| 주주지분 | $375억 | $386억 | $388억 | $393억 | $398억 | $477억 | $488억 | $506억 | $510억 | $521억 | $521억 | $511억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $155억 | $159억 | $146억 | $148억 | $150억 | $153억 | $132억 | $134억 | $129억 | $151억 | $340억 | $326억 | |
| 순차입금(차입금 - 현금) | $88.2억 | $89.8억 | $83억 | $77.7억 | $74.2억 | $76.6억 | $67.1억 | $64.9억 | $54.3억 | $65.5억 | $272억 | $275억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $186억 | $94.1억 | $38.4억 | $38.6억 | $68.4억 | $98억 | $98.8억 | $69억 | $76.2억 | $85.2억 | |
| 단기투자 | $1.55억 | $2.03억 | $2.42억 | $2.8억 | $3.1억 | $4.5억 | $2.88억 | $3.83억 | $3.51억 | $4.17억 | |
| 매출채권 | $32.5억 | $52.5억 | $51.8억 | $54.3억 | $64.1억 | $64.9억 | $62.2억 | $65.7억 | $69.3억 | $79.3억 | |
| 재고자산 | $24.3억 | $36억 | $38억 | $43.2억 | $50.1억 | $51.6억 | $61.7억 | $65.7억 | $61.9억 | $64.9억 | |
| 기타 유동자산 | $23.2억 | $16.9억 | $15.7억 | $17.9억 | $18.7억 | $23.5억 | $26.6억 | $22.6억 | $25.7억 | $26.4억 | |
| 유동자산 | $268억 | $201억 | $146억 | $157억 | $204억 | $242억 | $252억 | $227억 | $237억 | $260억 | |
| 유형자산(순액) | $57.1억 | $76.1억 | $75.6억 | $89.7억 | $101억 | $101억 | $103억 | $113억 | $117억 | $129억 | |
| 장기투자 | $29.5억 | $8.83억 | $8.97억 | $9.31억 | $10.3억 | $9.03억 | $7.66억 | $7.99억 | $8.86억 | $9.18억 | |
| 영업권 | $76.8억 | $240억 | $233억 | $232억 | $237억 | $232억 | $228억 | $237억 | $231억 | $240억 | |
| 무형자산 | $45.4억 | $215억 | $189억 | $170억 | $148억 | $127억 | $105억 | $88.2억 | $66.5억 | $55.3억 | |
| 이연법인세자산 | $40.2억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 비유동자산 | $33.5억 | $21.2억 | $18.9억 | $21억 | $24.2억 | $39.7억 | $49.2억 | $59.8억 | $154억 | $173억 | |
| 비유동자산 | $282억 | $561억 | $525억 | $522억 | $521억 | $510억 | $492억 | $505억 | $578억 | $607억 | |
| 자산총계 | $550억 | $763억 | $672억 | $679억 | $725억 | $752억 | $744억 | $732억 | $814억 | $867억 | |
| 부채 | |||||||||||
| 매입채무 | $11.8억 | $24억 | $29.8억 | $32.5억 | $39.5억 | $44.1억 | $46.1억 | $43억 | $42억 | $42.4억 | |
| 미지급비용 | $7.52억 | $11.9억 | $11.8억 | $12.4억 | $14.2억 | $16.3억 | $15.6억 | $16억 | $17억 | $17.5억 | |
| 단기차입금 | $13.3억 | $7.14억 | $2.07억 | $16.8억 | $4.61억 | $9.99억 | $24.8억 | $13.3억 | $17.5억 | $33.1억 | |
| 미지급세금 | $1.88억 | $3.09억 | $3.05억 | $2.26억 | $3.62억 | $3.06억 | $3.43억 | $4.92억 | $5.94억 | $5.69억 | |
| 기타 유동부채 | $32.2억 | $43억 | $43.4억 | $44.7억 | $57.2억 | $57.7억 | $65억 | $61.3억 | $59.1억 | $55.4억 | |
| 유동부채 | $66.6억 | $89.1억 | $90.1억 | $109억 | $119억 | $131억 | $155억 | $138억 | $142억 | $165억 | |
| 장기차입금 | $207억 | $272억 | $194억 | $167억 | $185억 | $173억 | $145억 | $136억 | $126억 | $108억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $7.55억 | $9.02억 | $9.56억 | $9.43억 | $9.49억 | $8.96억 | $9.31억 | |
| 이연법인세부채 | $27억 | $20.1억 | $20.6억 | $21.3억 | $21.5억 | $20.7억 | $18.4억 | $12.2억 | $13.7억 | $19.6억 | |
| 기타 비유동부채 | $42.5억 | $70.2억 | $60.2억 | $61.8억 | $60.6억 | $57.4억 | $47.4억 | $47.8억 | $44.6억 | $37.3억 | |
| 비유동부채 | $276억 | $362억 | $274억 | $257억 | $276억 | $261억 | $220억 | $205억 | $194억 | $174억 | |
| 부채총계 | $319억 | $452억 | $365억 | $366억 | $395억 | $392억 | $375억 | $344억 | $335억 | $339억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $130억 | $232억 | $235억 | $239억 | $241억 | $245억 | $247억 | $249억 | $252억 | $255억 | |
| 이익잉여금 | $256억 | $240억 | $246억 | $258억 | $276억 | $315억 | $353억 | $376억 | $473억 | $498억 | |
| 기타포괄손익누계액 | -$72.6억 | -$60.6억 | -$75.9억 | -$84.7억 | -$89.5억 | -$83.7억 | -$80.5억 | -$78.4억 | -$79.1억 | -$60억 | |
| 주주지분 | $205억 | $309억 | $305억 | $311억 | $328억 | $358억 | $367억 | $386억 | $477억 | $521억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $220억 | $279억 | $196억 | $191억 | $199억 | $193억 | $179억 | $159억 | $153억 | $151억 | |
| 순차입금(차입금 - 현금) | $33.9억 | $185억 | $157억 | $152억 | $131억 | $94.5억 | $80.6억 | $89.8억 | $76.6억 | $65.5억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
데이터 기준일 2026-11-01